Equities

Toleranzia AB

Toleranzia AB

Actions
  • Price (SEK)0.658
  • Today's Change0.006 / 0.92%
  • Shares traded78.40k
  • 1 Year change-18.16%
  • Beta1.2833
Data delayed at least 15 minutes, as of Jun 04 2024 16:29 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Toleranzia AB is a Sweden-based company engaged in the development of a platform technology for treatment of autoimmune diseases. The Company's main project is aimed against an autoimmune nerve-muscle disease and myasthenia gravis. The Company’s platform technology enables the development of therapies targeting the cause of the disease, which in the current situation is the usual treatment.

  • Revenue in SEK (TTM)0.00
  • Net income in SEK-6.30m
  • Incorporated2011
  • Employees7.00
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
NextCell Pharma AB12.45m-39.37m109.38m----1.18--8.79-0.9046-0.90460.2861.280.140614.067.20---44.45-34.92-50.09-37.0612.04-68.21-316.25-538.604.36--0.00--80.9672.85-15.21------
Odi Pharma AB (publ)818.38k-3.97m110.35m----54.19--134.83-0.2608-0.26080.05380.13380.10841.226.98---52.58---95.24---53.07---484.96--1.32-14.100.00---55.44--4.67------
Bioextrax AB publ1.63m-22.16m110.60m----6.04--67.93-0.8034-0.80340.05880.53150.0686--4.96---93.29-86.39-102.02-110.843.62---1,360.93-2,119.90----0.00--420.5124.40-15.21--56.86--
New Nordic Healthbrands AB537.81m-10.17m113.37m70.00--1.09--0.2108-1.64-1.6486.8116.862.161.844.967,367,219.00-4.095.36-9.1610.5565.3267.30-1.892.380.8584-4.440.282147.969.516.28-119.41--28.36--
Coegin Pharma AB0.00-27.98m113.92m0.00--8.75-----2.65-2.650.000.64030.00-------125.24-122.02-201.53-154.70-------28,466.75---170.650.00------20.60------
Isofol Medical AB (publ)0.00-31.16m115.81m4.00--1.03-----0.1964-0.19640.000.69930.00----0.00-20.49-66.73-24.10-88.27-------1,023.62----0.00---94.37--76.80------
StenoCare A/S6.25m-25.59m124.26m9.00--3.64--19.89-1.13-1.130.26741.220.1285--2.94---52.62-28.16-70.34-35.47-----409.55-371.061.04-5.560.2362---16.30---7.77------
Enorama Pharma AB670.00k-42.47m128.73m5.00--5.46--192.13-1.03-1.030.01630.42710.01840.75830.6384134,000.00-116.48-73.56-184.45-104.85-635.0743.36-6,338.66-557.420.4626-605.700.02---80.17-23.71-6.15------
Circa Group AS18.61m-71.41m135.47m17.00--0.3977--7.28-0.6578-0.65780.16892.800.04035.460.91391,098,678.00-15.46---19.96--75.64---383.72--0.7097--0.00--41.73---0.0491------
Toleranzia AB0.00-6.30m137.95m7.00--0.9032-----0.0405-0.04050.000.7750.00----0.00-4.50-7.45-4.65-7.78------------0.00------11.79--63.90--
PMD Device Solutions AB28.62m-36.18m139.69m1.00------4.88-16.69-16.696.34-4.790.9465--57.42---119.63------58.18---126.39--0.0505-3.00----------------
Bactiquant A/S18.73m-19.95m143.08m----6.52--7.64-0.6358-0.63580.59710.61330.50553.672.83---53.83-41.26-62.59-47.16-6.1412.89-106.51-71.775.43-8.540.0431---0.689--7.62------
Lipum AB (publ)0.00-37.18m145.31m5.00--14.50-----4.38-4.380.000.47260.00----0.00-159.35-127.85-206.31-184.50-------293,228.70----0.2781------2.38------
Xintela AB377.00k-49.24m152.52m--------404.57-0.1217-0.12170.0008-0.01360.0193--0.0447---252.59-181.06---391.61100.00---13,061.54-235,894.00---49.47-------45.5418.32---61.47--
Vo2 Cap Holding AB (publ)342.81m3.21m154.56m103.0047.640.6993.030.45090.06070.06076.504.130.7493--7.033,328,282.000.7023-0.25640.9347-0.383934.6223.360.9373-0.2409--1.180.1564---26.0985.65-57.92---17.96--
Vivesto AB0.00-116.73m165.45m6.00--0.8737-----0.219-0.2190.000.3520.00----0.00-44.08---47.15--------------0.00---100.00--64.80------
Data as of Jun 04 2024. Currency figures normalised to Toleranzia AB's reporting currency: Swedish Krona SEK
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.